SCHEMBL27496629

SCHEMBL27496629

O=C(Nc1ccc2c(c1)OCO2)c1sccc1S(=O)(=O)Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EDNRB P24530 1/20 0.60
▸ EDNRA P25101 1/20 0.60
▸ RAB9A P51151 17/20 0.57
▸ NPC1 O15118 15/20 0.57
▸ SMN1; SMN2 Q16637 12/20 0.57
▸ TP53 P04637 6/20 0.57
▸ NFKB1 P19838 5/20 0.57
▸ NFKB2 Q00653 5/20 0.57
▸ RELA Q04206 5/20 0.57
▸ HPGD P15428 4/20 0.57
▸ PKM P14618 3/20 0.57
▸ MEN1 O00255 6/20 0.56
▸ KMT2A Q03164 6/20 0.56
▸ ALDH1A1 P00352 3/20 0.56
▸ MAPT P10636 7/20 0.53
▸ POLB P06746 1/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ MAPK1 P28482 2/20 0.51
▸ USP2 O75604 1/20 0.51
▸ LMNA P02545 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27535427 0.82 EDNRA (0.66) EDNRBEDNRASMN1; SMN2HPGDMEN1
SCHEMBL6151248 0.78 EDNRA (0.81) EDNRBEDNRA
SCHEMBL27497626 0.77 KMT2A (0.57) EDNRBEDNRARAB9ANPC1SMN1; SMN2
SCHEMBL27496628 0.76 EDNRA (0.58) EDNRBEDNRARAB9ANPC1SMN1; SMN2
SCHEMBL6151116 0.76 EDNRA (1.00) EDNRBEDNRA
SCHEMBL7532022 0.73 HPGD (0.57) EDNRBEDNRARAB9ANPC1SMN1; SMN2
SCHEMBL27496308 0.73 TAS1R3 (0.47) EDNRBEDNRASMN1; SMN2HPGDMEN1
SCHEMBL471080 0.72 MAPT (0.57) EDNRBEDNRAHPGDPKMMEN1
SCHEMBL14701156 0.72 EDNRB (0.54) EDNRBEDNRAHPGDPKMMEN1
SCHEMBL12293031 0.72 EDNRB (0.54) EDNRBEDNRAHPGDPKMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1216045-A N- (2,1, 3-benzothia (oxa) diazolyl) sulfonamides having endothelin receptor antagonistic effect MERCK PATENT GMBH (DE) 1999-05-05 — — CN disclosed
Send feedback